India’s Perfint Develops Tools to Assist in Tumor Ablation
Chennai, India-based Perfint Healthcare, has developed MAXIO, an image-guided, physician controlled robotic system that assists physicians to visualize and plan an entire procedure such as tumor ablation in 3D. Once the plan is confirmed, MAXIO’s stereotactic arm, combined with intra-operative registration, assists surgeons to advance one or more instruments accurately to reach the target.
Founders S. Nandakumar, K. Guruswamy, K. Puhazhendi and Gopalakrishna Kulkarni spent a decade at GE Healthcare prior to creating this company. After talking to a number of radiologists and physicians in India, the team designed a product that is useful in treating tumors and managing pain rather than just diagnosing the tumor.
Maxio, an FDA 510k approved device is used in the U.S., Germany, Australia and India. . “It’s the best money can buy in two important areas of medical technology. There are similar systems that only the first world can afford, but this one is world-class, cost-effective and for me, this is true advancement in medicine,” says, Dr Yuman Fong, chair of surgery at City of Hope, the cancer research hospital in Duarte, California, reports Outlook Business.